3
Docon Technologies Pvt Ltd, a promoter entity of Thyrocare Technologies, has sold 53.33 lakh equity shares representing around 10% of the company’s total paid-up capital through open market transactions on October 24, 2025.
The sale was valued at Rs 667.7 crore at an average price of Rs 1,252 per share, according to a stock exchange filing.
Following the transaction, Docon’s shareholding in Thyrocare has come down from 71% to 61% and continues to remain a promoter of the diagnostics chain with 3.2 crore shares.
The block sale saw strong…
